Finance Lead, US Branded Pharmaceuticals @ Endo Pharmaceuticals (November 2014 - March 2016)
Sr. Finance Director, US Commercial Finance @ (July 2013 - November 2014)
Finance Director, R and D Performance, Strategy and Reporting @ (August 2012 - July 2013)
Global Project Team Finance Director @ (September 2009 - August 2012)
Brand Finance Manager @ (November 2006 - September 2009)
Sr. Financial Analyst, Financial Planning and Reporting @ (May 2004 - November 2006)
Senior Accountant @ (August 2001 - May 2004)
Chris Degnan Education
University of Notre Dame
Bachelor of Business Administration - BBA (Accounting)
1997-2001
Salesianum High School 1993-1997
Chris Degnan Skills
Financial Reporting
Financial Analysis
Finance
Forecasting
Sarbanes-Oxley Act
Strategic Financial Planning
Strategy
Cross-functional Team Leadership
Financial Planning
Accounting
Financial Modeling
Pharmaceutical Industry
Cross Functional Team Leadership
Analysis
Project Management
Customer Service
Microsoft Office
Strategic Planning
Sarbanes Oxley Act
Leadership
Sales
Chris Degnan Summary
Chris Degnan, based in Philadelphia, PA, US, is currently a Chief Financial Officer at UroGen Pharma. Chris Degnan brings experience from previous roles at Galera Therapeutics, Inc., Verrica Pharmaceuticals and Endo Pharmaceuticals. Chris Degnan holds a 1997 - 2001 Bachelor of Business Administration - BBA in Accounting @ University of Notre Dame. With a robust skill set that includes Financial Reporting, Financial Analysis, Finance, Forecasting, Sarbanes-Oxley Act and more. Chris Degnan has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Chris Degnan?
Find contact details for 700 million professionals.